CFLAR and cancer: The enumeration of circulating c-FLIP-expressing monocytes, in association with specific surface markers induced by FLIP, such as PD-L1, PD-L2 and CD38 can thus constitute a useful tool to refine the immunological landscape of cancer patients for a more correct diagnosis and treatment.